Cargando…

IFN-γ Mediates the Development of Systemic Lupus Erythematosus

OBJECTIVE: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect all organs in the body. It is characterized by overexpression of antibodies against autoantigen. Although previous bioinformatics analyses have identified several genetic factors underlying SLE, they did no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wenping, Li, Mengdi, Wang, Ziye, Wang, Jibo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586164/ https://www.ncbi.nlm.nih.gov/pubmed/33123584 http://dx.doi.org/10.1155/2020/7176515

Ejemplares similares

IFN-γ, should not be ignored in SLE
por: Liu, Wenping, et al.
Publicado: (2022)

Serum IFN‐γ Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients
por: Wang, Dandan, et al.
Publicado: (2017)

Identification of Peptides as Novel Inhibitors to Target IFN-γ, IL-3, and TNF-α in Systemic Lupus Erythematosus
por: Mustafa, Ghulam, et al.
Publicado: (2021)

Association of the STAT4 Gene rs7574865 Polymorphism with IFN-γ Levels in Patients with Systemic Lupus Erythematosus
por: Esparza Guerrero, Yussef, et al.
Publicado: (2023)

IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus
por: Ding, Xuewei, et al.
Publicado: (2020)

IFN-gamma transgenic mice: clues to the pathogenesis of systemic lupus erythematosus?
por: Seery, John P
Publicado: (2000)

Blood Genomics Identifies Three Subtypes of Systemic Lupus Erythematosus: “IFN-High,” “NE-High,” and “Mixed”
por: Cui, Mintian, et al.
Publicado: (2021)

Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus
por: Yao, Yihong, et al.
Publicado: (2009)

TNF-α − 308 G > A and IFN-γ + 874 A > T gene polymorphisms in Egyptian patients with lupus erythematosus
por: Al-Kholy, Wfaa, et al.
Publicado: (2016)

Impact of IL-34, IFN-α and IFN-λ1 on activity of systemic lupus erythematosus in Egyptian patients
por: Adel, Yasmin, et al.
Publicado: (2020)

The Oxysterol Receptor EBI2 Links Innate and Adaptive Immunity to Limit IFN Response and Systemic Lupus Erythematosus
por: Zhang, Fang, et al.
Publicado: (2023)

IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE)
por: Oke, Vilija, et al.
Publicado: (2017)

AKT2 reduces IFNβ1 production to modulate antiviral responses and systemic lupus erythematosus
por: Zheng, Xin, et al.
Publicado: (2022)

Clinical features of central nervous system infections and experience in differential diagnosis from neuropsychiatric lupus erythematosus in a cohort of 8491 patients with systemic lupus erythematosus
por: Jiang, Mengdi, et al.
Publicado: (2019)

Genetic Modifiers of Systemic Lupus Erythematosus in FcγRIIB(−/−) Mice
por: Bolland, Silvia, et al.
Publicado: (2002)

IL-2, IL-5, TNF-α and IFN-γ mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesions
por: Carneiro, José Ronaldo M, et al.
Publicado: (2011)

A pathogenic IFNα, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients
por: López, Patricia, et al.
Publicado: (2016)

Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus
por: Sakata, Kei, et al.
Publicado: (2018)

Systemic lupus erythematosus.
por: Richardson, J.
Publicado: (1969)

MALAT1 is involved in type I IFNs-mediated systemic lupus erythematosus by up-regulating OAS2, OAS3, and OASL
por: Gao, Fei, et al.
Publicado: (2020)

New developments in systemic lupus erythematosus
por: Tsang-A-Sjoe, Michel W. P., et al.
Publicado: (2021)

Antibodies against type I IFN: The bad guys self-restrain in systemic lupus erythematosus
por: Fillatreau, Simon
Publicado: (2023)

Neutrophil FcγRIIA availability is associated with disease activity in systemic lupus erythematosus
por: Bengtsson, Anders A., et al.
Publicado: (2020)

IFN-γ Mediates the Rejection of Haematopoietic Stem Cells in IFN-γR1-Deficient Hosts
por: Rottman, Martin, et al.
Publicado: (2008)

IFN-α induced systemic lupus erythematosus complicated with hemophagocytic lymphohistiocytosis: a case report and literature review
por: Zeng, Zhipeng, et al.
Publicado: (2023)

Elevated Apoptosis and Impaired Proliferation Contribute to Downregulated Peripheral γ δ T Cells in Patients with Systemic Lupus Erythematosus
por: Lu, Zhimin, et al.
Publicado: (2013)

Systemic lupus erythematosus with nephropathy.
por: Hayslett, J. P., et al.
Publicado: (1995)

Systemic Lupus Erythematosus
por: Peng, Stanford
Publicado: (1993)

Systemic lupus erythematosus
por: Manson, Jessica J, et al.
Publicado: (2006)

Systemic Lupus Erythematosus
por: Putterman, Chaim, et al.
Publicado: (2012)

Systemic Lupus Erythematosus
por: Okamoto, Hiroshi, et al.
Publicado: (2012)

Role of lupus retinopathy in systemic lupus erythematosus
por: Kharel (Sitaula), Ranju, et al.
Publicado: (2016)

Development of targeted biologics for systemic lupus erythematosus
por: Lipsky, Peter E
Publicado: (2012)

Replication of the genetic effects of IFN regulatory factor 5 (IRF5) on systemic lupus erythematosus in a Korean population
por: Shin, Hyoung Doo, et al.
Publicado: (2007)

Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?
por: Wahadat, M. Javad, et al.
Publicado: (2018)

Association Between the Interferon-γ +874 T/A Polymorphism and the Risk and Clinical Manifestations of Systemic Lupus Erythematosus: A Preliminary Study
por: Liu, Shanshan, et al.
Publicado: (2021)

Secondary angle-closure glaucoma as an ocular presentation of systemic lupus erythematosus: a case report
por: Hou, Xincen, et al.
Publicado: (2020)

Clinical Characteristics of Systemic Lupus Erythematosus with Cirrhosis
por: You, Hanxiao, et al.
Publicado: (2020)

Subacute cutaneous lupus erythematosus and systemic lupus erythematosus associated with abatacept
por: Tarazi, Meera, et al.
Publicado: (2018)

Lupus nephropathy as the initial manifestation of systemic lupus erythematosus.
por: Lynn, R. I., et al.
Publicado: (1980)

Cannot write session to /tmp/vufind_sessions/sess_cikaom9f9l7el648ptcdgrt5rc